| INTRODUCTION
Colorectal cancer is the third most common malignancy and the fourth leading cause of cancer-related deaths worldwide, accounting for about 1.4 million new cases and almost 700 000 deaths annually. 1 Rectal cancer presently accounts for 30-40% of all colorectal cancers. 2, 3 Anastomotic leak (AL) is a serious complication after low anterior resection (LAR) for rectal cancer. It increases short-term morbidity and medical costs, prolongs hospital stay, and can be fatal. 4 The incidence of AL after LAR varies from 5% to 16%, [5] [6] [7] [8] [9] and a meta-analysis revealed that AL has a negative prognostic impact on local recurrence and long-term survival in rectal cancer. 10 Since the 1980s, total mesorectal excision (TME) and tumorspecific mesorectal excision (TSME) have been standard techniques for rectal surgery because they decrease the risk of local recurrence.
with improved oncological and functional outcomes. 13, 14 However, despite these advances, the number of high-risk cases of AL has also increased. 9 Meta-analyses have reported that a diverting stoma (DS) decreases the incidence of symptomatic AL and/or the need for reoperation after LAR. 15, 16 However, in clinical practice, we construct a DS only for high-risk patients, given the risks of stoma-related complications and worsened quality of life, as well as the need for an additional operation for stoma closure. 17, 18 Recent reports showed that placement of a transanal tube after LAR could decrease the incidence of AL. [19] [20] [21] We previously reported that lack of transanal tube placement may be a risk factor for AL after laparoscopic LAR. 22 Transanal tube placement is both time-and costeffective, and compared with a DS, is much less invasive. However, as few studies have investigated the effectiveness of transanal tube placement, this study sought to evaluate its effectiveness for prevention of AL after LAR.
| METHODS
Data for this multicenter, retrospective cohort study were collected from Kyoto University Hospital and two affiliated hospitals (Nishi-Kobe Medical Center and Saiseikai Noe Hospital). The study was approved by the ethics committees of all three participating hospitals. The primary endpoint was the incidence of symptomatic AL. We also investigated the prognostic impact of symptomatic AL.
| Patients
We collected surgical and prognostic data along with clinicopathologic 
| Surgical method
All patients received standard bowel preparation and antibiotic prophylaxis. All operations were performed by or with the assistance of skilled colorectal surgeons and were based on guidelines approved by the Japanese Society for Cancer of the Colon and Rectum. 23 The standard surgical technique performed was TME or TSME, the main principle of which is sharp mesorectal dissection with nerve preservation. All anastomoses were performed with an end-to-end double stapling technique using a circular stapler. Cases requiring conversion to open surgery were regarded as laparoscopic. The decision to create a DS was made by the operating surgeon.
For transanal tube placement, a silicone or rubber tube (10 mm in diameter) was positioned such that the top of the tube was located 3-5 cm above the anastomotic site with visual or palpatory control in order to avoid injury to the anastomotic site or intestinal wall. The tube was anchored to the buttocks with sutures and hooked to a drainage bag and usually kept in place for 4-6 days. We removed the tube at the bedside after watery stool came out of the tube.
| Definition of symptomatic anastomotic leak
Clinical symptoms caused by AL were defined as emission of gas, pus, or feces from the abdominal drain or wound or from the vagina.
All clinically suspicious symptoms, including fever, peritonitis, or turbid discharge from an abdominal drain, were confirmed on digital rectal examination, sigmoidoscopy, computed tomography, and/or contrast enema. We defined AL as AL diagnosed within 30 days of surgery.
Severity of AL was classified according to the system proposed by the International Study Group of Rectal Cancer in 2010: grade A, no change in patient management needed; grade B, active therapeutic intervention required but manageable without reoperation; or grade C, reoperation required. 24 Symptomatic AL was defined as grade B or C.
| Statistical analysis
Patient demographic and surgical data are summarized as numbers or medians with interquartile range (IQR) or as prevalence, as appropriate. and the log-rank test was used for analysis.
All analyses were two-sided and considered statistically significant at P < 0.05. Data analysis was performed using JMP® 11 software (SAS Institute Inc., Cary, NC).
3 | RESULTS
| Patient characteristics
Of 359 patients considered for inclusion, 328 were eligible; the 31 patients excluded had either undergone transanal hand-sewn anastomosis (n = 25) or high anterior resection (n = 6). The incidence of symptomatic AL was 11% (36/328). There were 205 patients in the TA group and 123 patients in the non-TA group. In multivariable analysis, transanal tube placement significantly decreased symptomatic AL (adjusted OR 0.37, 95%CI 0.15-0.91).
| Anastomotic leak
Presence of diabetes and long operation time (≥5 h) were identified as statistically significant covariates (Table 3) .
After stratification of the independent risk factors for AL, we performed a subgroup analysis of the effectiveness of transanal tube placement. Figure Table 4 and Fig. 2 show postoperative outcome in the two groups.
| Postoperative outcome
Overall operative morbidity (grade ≥II, grade ≥IIIa) occurred in 106 patients (32%) and 37 patients (11%), respectively. Ninetyday mortality was 0.61% (2/328), and both deaths were in (Fig. 2(A) ), but the rate tended to be higher in patients with symptomatic AL than in those without symptoms (3/36 and 10/292, respectively; log-rank test, P = 0.087; Fig. 2(B) ).
| DISCUSSION
Our results demonstrate that transanal tube placement contributes to a decreased risk of symptomatic AL after LAR. To our knowledge, this is the first multicenter study to evaluate the impact of transanal tube placement on prevention of AL after LAR.
AL is presumably associated with increased intraluminal pressure. 20 In the early postoperative period, the anal sphincter is in a state of spasm, leading to high intraluminal pressure, and therefore transanal decompression and drainage may help prevent AL. A transanal tube can decrease intraluminal pressure by providing effective drainage on the proximal side of the anastomosis. A DS is thought to work via a similar mechanism.
Several single-center studies have suggested that transanal tube placement is effective in reducing AL. 20, 21, 25, 26 The reported incidence of AL in patients with a transanal tube is 2.7-4.1% versus 7.8-16% in those without one. The incidence of AL in our TA group (8.3%) was higher than in previous studies because we included patients at highrisk for AL including male sex and lower anastomosis level. 25, 27 In clinical practice, surgeons tend to place a transanal tube in a patient with more risk factors for AL; however, the data reported previously were subjected to univariable and not multivariable analysis. 21, 25, 26 Furthermore, most previous studies involved small numbers of patients with a transanal tube and excluded patients with a DS, 19, 21, 25 so there was no adjustment for confounding factors. Using both univariable and multivariable analyses, we showed that transanal tube placement can decrease the incidence of symptomatic AL after LAR.
We found a tendency, albeit not significant, for the transanal tube to decrease grade C AL. However, due to the limited number of events, our study might have lacked the power needed to detect a true effect.
Considering only patients with grade C AL, the median time to reoperation was longer in the TA group than in the non-TA group (13 days vs 3.5 days, P = 0.24). This could be because of a reduction in the severity of AL as a result of the transanal tube and therefore a decreased number of patients requiring emergency reoperation.
However, emergency reoperation was performed in three cases each in the TA group (1.5%) and non-TA group (2.4%; P = 0.68). Possible reasons for the lack of a significant difference in the reoperation rate include the limited number of events and the fact that reoperation may have been delayed due to the presence of the transanal tube. This may also account for the longer time to reoperation in the TA group. All patients with grade C AL required ileostomy. We believe that a DS should be created for high-risk patients in whom AL cannot be prevented by placing a transanal tube. Several risk factors for AL have been reported, including male sex, obesity, neoadjuvant therapy, a lower level of anastomosis, larger tumor size, and absence of a DS. 9, 20, 22, 27, 28 Our study indicates that diabetes, longer operation time (≥5 h), and no transanal tube placement were risk factors for AL, which is consistent with previous reports. 21, 25, 27, 29 When the operation time is longer than expected, a DS needs to be created because the OR was particular high for this risk factor (9.31 [95%CI 3.25-32.5]) in our study. The effectiveness of a transanal tube was poor in our subgroup of patients with a DS, so it may not be necessary to combine the two procedures.
Transanal tube placement did not affect postoperative morbidity, mortality, length of hospital stay, or local recurrence rate (Table 4 and Fig. 2(A) ). However, there were 2 cases of thrombosis and 1 perforation in the TA group. A transanal tube might cause thrombosis by making postoperative ambulation more difficult so early ambulation is recommended for these patients, as is the case without a transanal tube. The patient who had perforation had multiple diverticula in the sigmoid colon, and there are some reports of bowel perforation in association with a transanal tube. 21 Therefore, care should be taken to ensure that the transanal tube does not perforate the colon, especially in patients with multiple diverticula.
Consistent with previous studies, 10 we found that AL tended to increase the local recurrence rate (Fig. 2(B) ). Therefore, transanal tube placement might reduce the risk of local recurrence indirectly.
This study has several limitations. First is its retrospective cohort design. Although we included recent data generated in the last 5 years, better outcomes may simply reflect improvements over time rather than changes related to a specific intervention when a historical control is In conclusion, transanal tube placement may decrease the incidence of symptomatic AL after LAR, and is a less invasive method than creation of a DS for prevention of AL.
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